Table 2.
Treatment type | Medication | Considerations |
---|---|---|
Topical | 2% minoxidil solution 1–2 times/day; 5% minoxidil foam once daily | Can cause scalp irritation |
Systemic | Finasterine 1 mg once daily; dutasterine 0.5–2.5 mg once daily | Suggested use of concurrent contraception if used in premenopausal women. Sexual AEs |
Cyproterone acetate 100 mg/day on days 5–15 of menstrual cycle | Studied in premenopausal women only | |
Spironolactone 100–200 mg once daily | Electrolytes should be monitored 1 week after starting or after dose change, and then every 3 months | |
Minoxidil 0.25–2.5 mg once daily | Caution recommended in history of cardiac disease | |
Nutritional supplements (including B vitamins and zinc) | Further research needed to establish standardized dosing | |
Surgical | Hair transplant | Requires adequate hair density at donor site |
Other | Platelet‐rich plasma | Further research required into outcomes and dosing regimens |
Low‐level laser | ||
Camouflage/hairpieces/wigs |
AE, adverse effect.